SpringWorks Therapeutics Completes $125 Million Series B Financing
Go back to SpringWorks Therapeutics Completes $125 Million Series B Financing| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.86 | 52 Week High | $45.58 | |||
| Open | $52.86 | 52 Week Low | $37.82 | |||
| Day High | $52.86 | P/E | N/A | |||
| Day Low | $52.86 | EPS | $0.00 | |||
| Volume | 9,475 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.86 | 52 Week High | $45.58 | |||
| Open | $52.86 | 52 Week Low | $37.82 | |||
| Day High | $52.86 | P/E | N/A | |||
| Day Low | $52.86 | EPS | $0.00 | |||
| Volume | 9,475 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.17 --26.17 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $37.39 | |||
| Open | $26.17 | 52 Week Low | $28.25 | |||
| Day High | $26.17 | P/E | 15.86 | |||
| Day Low | $26.17 | EPS | $1.65 | |||
| Volume | 31,747 | |||||

